ReviewJournal of applied biomedicine2019
Takayasu arteritis - epidemiology, pathogenesis, diagnosis and treatment.
Review in Journal of applied biomedicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Surgical management of type IV thoracoabdominal aortic aneurysm in a 4-year-old child: A case report and review of the literature.Journal of vascular surgery cases and innovative techniques · 2026Article
- Pulmonary arteritis in the course of granulomatosis with polyangiitis.Rheumatology international · 2025Review
- Exceptional multisite aneurysms in Takayasu arteritis: A unique and challenging case.Radiology case reports · 2024Article
- Adolescent Takayasu's arteritis with hypertensive intracerebral hemorrhage: a case report and literature review.Frontiers in pediatrics · 2024Article
- Isolated pulmonary artery involvement in Takayasu arteritis: case report and review of the literature.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2023Article
- An Interesting Case of Takayasu Arteritis With Acute Bilateral Pulmonary Thromboembolism.Cureus · 2023Article
- The impact of the COVID-19 pandemic on patients with systemic vasculitis: a single-centre retrospective study.Rheumatology international · 2023Article
- Coronary artery lesions in Takayasu arteritis.Reumatologia · 2023Review
- Takayasu's Arteritis: Is Age a Differential Factor in the Diagnosis, Follow-Up, and Treatment of the Disease?Arquivos brasileiros de cardiologia · 2023Article
- Giant Cell Arteritis: A Case-Based Narrative Review of the Literature.Current pain and headache reports · 2022Review
- Unilateral pleural effusion secondary to Takayasu arteritis: a case report and literature review.Journal of biomedical research · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Takayasu disease belongs to the group of autoimmune vasculitis which most often affects the aorta and its branches. It is rare, and it mainly affects young women. Recent epidemiologic studies suggest that Takayasu arteritis is being increasingly recognized in Europe. The first symptoms are non-specific and an early diagnosis is difficult and requires clinical awareness and suspicion. Patients with Takayasu arteritis often present increased inflammatory markers, including C-reactive protein and erythrocyte sedimentation rate, but systemic inflammatory response does not always show a positive correlation with inflammatory activity in the vessel wall. Therefore, imaging studies play a principal role in diagnosis and control of the disease. Glucocorticoids remain the most effective and serve as a cornerstone first line treatment. Immunosuppressive drugs play an important role as well, and biological therapy is increasingly being included in the treatment. This article describes the epidemiology, pathophysiology, diagnostics and treatment of this rare disease, so as to alert clinicians because disease left untreated can lead to narrowing and even closure of vital blood vessels. The most common Takayasu arteritis complications include pulmonary thrombosis, aortic regurgitation, congestive heart failure, cerebrovascular events, vision degeneration or blindness, and hearing problems.
Indexed as
Identifiers
34907753What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.